Area of research
Immunology · Obstetrics and Gynecology
Research interest
Research interests include Complement system in diseases, Gestational Diabetes Research and Management, Lymphoma Diagnosis and Treatment, and Immunotherapy and Immune Responses.
Glycated CD59, a Novel Biomarker for Gestational Diabetes.
CD59 double knockout mice express a CD59ba hybrid fusion protein that mediates insulin secretion.
The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland
The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland
Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol
The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia—Subanalysis of the DALI Study
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland
Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes
Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns
Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns.
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance